An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries

European Urology

Volumn 47, Issue 6, 2005, Pages 846-854

  Mirone, Vincenzo ^a   Costa, Pierre ^b   Damber, Jan Erik ^c   Holmes, Simon ^d   Moncada, Ignacio ^e   Van Ahlen, Hermann ^f   Wespes, Eric ^g   Cordell, William H ^h   Chan, Melanie ^h   Lembo, Danilo ⁱ   Varanese, Lucio ^j  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Hopital Gaston Doumergue   (France)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d ST MARY S HOSPITAL   (United Kingdom)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f Clinic for Urology   (Germany)

^g Centre Hospitalier Universitaire de Charleroi   (Belgium)

^h ELI LILLY AND COMPANY   (United States)

ⁱ Ely Lilly Italy   (Italy)

^j Erl Wood Research Center   (United Kingdom)

more..

Author keywords

3 times week; Alternate; Erectile dysfunction; On demand; SURE study; Tadalafil

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; TADALAFIL;

ABDOMINAL PAIN; ADULT; AGE DISTRIBUTION; ARTICLE; BACKACHE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG PREFERENCE; DRUG RESPONSE; DRUG TOLERABILITY; DYSPEPSIA; ERECTILE DYSFUNCTION; FLUSHING; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTICENTER STUDY; MYALGIA; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SIDE EFFECT;

EID: 21144476846     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.02.019     Document Type: Article

References (8)

1. G.B. Brock, C.G. McMahon, K.K. Chen, T. Costigan, W. Shen, and V. Watkins Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses J Urol 168 2002 1332
2. Hellstrom WJG, M. Gittelman, G. Karlin, T. Segerson, M. Thibonnier, and T. Taylor Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial J Androl 23 2002 763
3. G. Goldstein, T.F. Lue, H. Padma-Nathan, R. Rosen, W. Steers, and Wicker PA Oral sildenafil in the treatment of erectile dysfunction N Engl J Med 338 1998 1397
4. H. Porst, H. Padma-Nathan, F. Giuliano, G. Anglin, L. Varanese, and R. Rosen Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial Urology 62 1 2003 1
5. R.C. Rosen, A. Riley, G. Wagner, I.H. Osterloh, J. Kirkpatrick, and A. Mishra The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction Urology 49 1997 822
6. J.C. Cappelleri, R.C. Rosen, M.D. Smith, A. Mishra, and I.H. Osterloh Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function Urology 54 1999 346
7. H.A. Feldman, I. Goldstein, D.G. Hatzichristou, R.J. Krane, and J.B. McKinlay Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study J Urol 151 1994 54
8. C.C. Carson, J. Rajfer, I. Eardley, S. Carrier, J.S. Dennes, and D.J. Walker The efficacy and safety of tadalafil: an update BJU Int. 93 9 2004 1276